| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | Nilotinib | CTRPv2 | pan-cancer | AAC | -0.0028 | 0.9 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.0027 | 0.9 |
| mRNA | masitinib | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | BRD-K37390332 | CTRPv2 | pan-cancer | AAC | -0.0026 | 0.9 |
| mRNA | Repligen 136 | CTRPv2 | pan-cancer | AAC | 0.0025 | 0.9 |
| mRNA | KIN001-055 | GDSC1000 | pan-cancer | AAC | 0.0022 | 0.9 |
| mRNA | erismodegib | CTRPv2 | pan-cancer | AAC | 0.0024 | 1 |
| mRNA | BRD8899 | CTRPv2 | pan-cancer | AAC | 0.0023 | 1 |
| mRNA | ML312 | CTRPv2 | pan-cancer | AAC | -0.0043 | 1 |
| mRNA | 17-AAG | GDSC1000 | pan-cancer | AAC | -0.0011 | 1 |